risk of semaglutide Semaglutide: What we know about safety and cancer Risk of Stroke in Real-World
Description
Future Research on Brain Effects The clinical investigation of incretin medications in terms of their influence on brain health is of more interest to scientists
Limited Visibility In a 1:1 matched case-control study performed by Chapman et al., patients getting GLP-1 RAs had significantly lower visibility scores during EGD and were 4.62 times more likely to have retained gastric contents compared to patients not on GLP-1 RAs ( p -value 0.025) [23]
Slowing the Rate of Digestion GLP-1 receptor agonists slow gastric emptying and the motility of the small intestine
2022 doi: 10.14309/ajg.0000000000003213
[7] Rosenstock J, et al
Griauzde DH, Ibrahim AM, Fisher N, Stricklen A, Ross R, Ghaferi AA
